CRISPR/dCas9-mediated transposition with specificity and efficiency of site-directed genomic insertions

Lena Goshayeshi1,2, Sara Yousefi Taemeh1,2, Nima Dehdilani1,2

  • 1Division of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.

Insights

Researchers developed a novel RNA-guided piggyBac transposase system for precise DNA integration. This method overcomes limitations of traditional gene editing, enabling targeted genomic insertions with potential applications in cancer therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Current targeted nucleases for genome editing have limited efficiency for sequence replacements or insertions.
  • Limitations include reliance on DNA repair pathways, potential cellular toxicity, and proto-oncogene activation.
  • The piggyBac (PB) transposase offers efficient, albeit random, DNA integration into the genome.

Purpose of the Study:

  • To develop a method for site-directed DNA integration using a fusion of catalytically inactive Cas9 (dCas9) and PB transposase.
  • To enhance precision and efficiency in genomic insertions by guiding the PB transposase to specific DNA targets.
  • To establish a system for recovering cells with successful targeted integrations.

Main Methods:

  • Fused catalytically inactive Cas9 (dCas9) to the piggyBac (PB) transposase.
  • Utilized dual single-guide RNAs (sgRNAs) to direct the dCas9-PB fusion to specific genomic locations.
  • Employed a promoter/reporter complementation assay to identify and select cells with accurate genomic integrations.

Main Results:

  • Achieved site-directed integrations into the human ROSA26 safe harbor region using the RNA-guided PB transposase system.
  • Demonstrated successful targeting with an efficiency of 0.32% of cells.
  • Validated the functionality of the promoter/reporter complementation assay for detecting specific integrations.

Conclusions:

  • The developed RNA-guided piggyBac transposase methodology enables precise targeting of specific genomic regions.
  • This approach offers a potential solution to the limitations of existing gene editing technologies.
  • Potential applications include targeted sequence insertion in cancer cells for therapeutic purposes, such as activating tumor suppressor genes or inserting sequences for destruction.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.0K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.4K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
54.9K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
59.1K
DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
15.8K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.2K